Substituted phenidates: Difference between revisions

>Unity
m For tutorial.
>Unity
Undo revision 110368 by Clarity (talk)
Line 7: Line 7:
==Pharmacology==
==Pharmacology==
{{pharmacology}}
{{pharmacology}}
Substituted phenidates primarily act as [[reuptake inhibitors]] of the [[monoamine]] [[neurotransmitters]] [[dopamine]], [[norepinephrine]], and to a minor degree, [[serotonin]].{{citation needed}}
Substituted phenidates primarily act as [[reuptake inhibitors]] of the [[monoamine]] [[neurotransmitters]] [[dopamine]], [[norepinephrine]], and to a much lesser degree, [[serotonin]]. One study found that all substituted phenidates inhibited the norepinephrine and dopamine reuptake transporters 4 to >1,000-fold more potently than the serotonin transporter.<ref>Luethi, D., Kaeser, P. J., Brandt, S. D., Krähenbühl, S., Hoener, M. C., & Liechti, M. E. (2017). Pharmacological profile of methylphenidate-based designer drugs. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2017.08.020</ref>


== List of substituted phenidates ==
== List of substituted phenidates ==
Line 42: Line 42:
==See also==
==See also==
*[[Responsible use]]
*[[Responsible use]]
*[[Psychedelics]]
*[[Phenethylamines]]
*[[Phenethylamines]]
*[[Substituted amphetamine]]
*[[Substituted amphetamine]]
*[[Entactogens]]
*[[Entactogens]]
*[[Stimulants]]
*[[Stimulants]]
==Literature==
* Luethi, D., Kaeser, P. J., Brandt, S. D., Krähenbühl, S., Hoener, M. C., & Liechti, M. E. (2017). Pharmacological profile of methylphenidate-based designer drugs. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2017.08.020
==References==
<references />


[[Category:Phenidate]]
[[Category:Phenidate]]